Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data.

Rosenfeld AM, Meng W, Luning Prak ET, Hershberg U.

Front Immunol. 2018 Sep 21;9:2107. doi: 10.3389/fimmu.2018.02107. eCollection 2018.

2.

Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life.

Miron M, Kumar BV, Meng W, Granot T, Carpenter DJ, Senda T, Chen D, Rosenfeld AM, Zhang B, Lerner H, Friedman AL, Hershberg U, Shen Y, Rahman A, Luning Prak ET, Farber DL.

J Immunol. 2018 Oct 1;201(7):2132-2140. doi: 10.4049/jimmunol.1800716. Epub 2018 Aug 15.

PMID:
30111633
3.

Computational Evaluation of B-Cell Clone Sizes in Bulk Populations.

Rosenfeld AM, Meng W, Chen DY, Zhang B, Granot T, Farber DL, Hershberg U, Luning Prak ET.

Front Immunol. 2018 Jun 29;9:1472. doi: 10.3389/fimmu.2018.01472. eCollection 2018.

4.

Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data.

Breden F, Luning Prak ET, Peters B, Rubelt F, Schramm CA, Busse CE, Vander Heiden JA, Christley S, Bukhari SAC, Thorogood A, Matsen Iv FA, Wine Y, Laserson U, Klatzmann D, Douek DC, Lefranc MP, Collins AM, Bubela T, Kleinstein SH, Watson CT, Cowell LG, Scott JK, Kepler TB.

Front Immunol. 2017 Nov 1;8:1418. doi: 10.3389/fimmu.2017.01418. eCollection 2017.

5.

Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data.

Rubelt F, Busse CE, Bukhari SAC, Bürckert JP, Mariotti-Ferrandiz E, Cowell LG, Watson CT, Marthandan N, Faison WJ, Hershberg U, Laserson U, Corrie BD, Davis MM, Peters B, Lefranc MP, Scott JK, Breden F; AIRR Community, Luning Prak ET, Kleinstein SH.

Nat Immunol. 2017 Nov 16;18(12):1274-1278. doi: 10.1038/ni.3873. No abstract available.

6.

Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Hanley P, Sutter JA, Goodman NG, Du Y, Sekiguchi DR, Meng W, Rickels MR, Naji A, Luning Prak ET.

Clin Immunol. 2017 Oct;183:336-343. doi: 10.1016/j.clim.2017.09.021. Epub 2017 Sep 23.

7.

An atlas of B-cell clonal distribution in the human body.

Meng W, Zhang B, Schwartz GW, Rosenfeld AM, Ren D, Thome JJC, Carpenter DJ, Matsuoka N, Lerner H, Friedman AL, Granot T, Farber DL, Shlomchik MJ, Hershberg U, Luning Prak ET.

Nat Biotechnol. 2017 Sep;35(9):879-884. doi: 10.1038/nbt.3942. Epub 2017 Aug 21.

8.

ImmuneDB: a system for the analysis and exploration of high-throughput adaptive immune receptor sequencing data.

Rosenfeld AM, Meng W, Luning Prak ET, Hershberg U.

Bioinformatics. 2017 Jan 15;33(2):292-293. doi: 10.1093/bioinformatics/btw593. Epub 2016 Sep 11.

9.

B cell development in chromosome 22q11.2 deletion syndrome.

Derfalvi B, Maurer K, McDonald McGinn DM, Zackai E, Meng W, Luning Prak ET, Sullivan KE.

Clin Immunol. 2016 Feb;163:1-9. doi: 10.1016/j.clim.2015.12.004. Epub 2015 Dec 10.

PMID:
26689329
10.

Genetic sharing and heritability of paediatric age of onset autoimmune diseases.

Li YR, Zhao SD, Li J, Bradfield JP, Mohebnasab M, Steel L, Kobie J, Abrams DJ, Mentch FD, Glessner JT, Guo Y, Wei Z, Connolly JJ, Cardinale CJ, Bakay M, Li D, Maggadottir SM, Thomas KA, Qui H, Chiavacci RM, Kim CE, Wang F, Snyder J, Flatø B, Førre Ø, Denson LA, Thompson SD, Becker ML, Guthery SL, Latiano A, Perez E, Resnick E, Strisciuglio C, Staiano A, Miele E, Silverberg MS, Lie BA, Punaro M, Russell RK, Wilson DC, Dubinsky MC, Monos DS, Annese V, Munro JE, Wise C, Chapel H, Cunningham-Rundles C, Orange JS, Behrens EM, Sullivan KE, Kugathasan S, Griffiths AM, Satsangi J, Grant SF, Sleiman PM, Finkel TH, Polychronakos C, Baldassano RN, Luning Prak ET, Ellis JA, Li H, Keating BJ, Hakonarson H.

Nat Commun. 2015 Oct 9;6:8442. doi: 10.1038/ncomms9442.

11.

Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.

Kolhatkar NS, Brahmandam A, Thouvenel CD, Becker-Herman S, Jacobs HM, Schwartz MA, Allenspach EJ, Khim S, Panigrahi AK, Luning Prak ET, Thrasher AJ, Notarangelo LD, Candotti F, Torgerson TR, Sanz I, Rawlings DJ.

J Exp Med. 2015 Sep 21;212(10):1663-77. doi: 10.1084/jem.20150585. Epub 2015 Sep 14.

12.

The analysis of clonal expansions in normal and autoimmune B cell repertoires.

Hershberg U, Luning Prak ET.

Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676). pii: 20140239. doi: 10.1098/rstb.2014.0239. Review.

13.

Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis.

Walter JE, Lo MS, Kis-Toth K, Tirosh I, Frugoni F, Lee YN, Csomos K, Chen K, Pillai S, Dunham J, Tsokos GC, Luning Prak ET, Notarangelo LD.

J Allergy Clin Immunol. 2015 Jan;135(1):272-3. doi: 10.1016/j.jaci.2014.07.063. Epub 2014 Oct 11. No abstract available.

14.

RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the nature of 'alternative NHEJ'.

Gigi V, Lewis S, Shestova O, Mijušković M, Deriano L, Meng W, Luning Prak ET, Roth DB.

Nucleic Acids Res. 2014 Jun;42(10):6352-64. doi: 10.1093/nar/gku295. Epub 2014 Apr 20.

15.

Facile method for the site-specific, covalent attachment of full-length IgG onto nanoparticles.

Hui JZ, Al Zaki A, Cheng Z, Popik V, Zhang H, Luning Prak ET, Tsourkas A.

Small. 2014 Aug 27;10(16):3354-63. doi: 10.1002/smll.201303629. Epub 2014 Apr 14.

16.

Trials and Tribulations with VH Replacement.

Meng W, Jayaraman S, Zhang B, Schwartz GW, Daber RD, Hershberg U, Garfall AL, Carlson CS, Luning Prak ET.

Front Immunol. 2014 Jan 30;5:10. doi: 10.3389/fimmu.2014.00010. eCollection 2014. Review.

17.

Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.

Hershberg U, Meng W, Zhang B, Haff N, St Clair EW, Cohen PL, McNair PD, Li L, Levesque MC, Luning Prak ET.

Arthritis Res Ther. 2014 Feb 11;16(1):R51. doi: 10.1186/ar4481.

18.

Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine.

Chu CS, Boyer JD, Jawad A, McDonald K, Rogers WT, Luning Prak ET, Sullivan KE.

Vaccine. 2013 Nov 4;31(46):5435-42. doi: 10.1016/j.vaccine.2013.09.001. Epub 2013 Sep 13.

19.

Antibodies that bind complex glycosaminoglycans accumulate in the Golgi.

Radic M, Weigert MG, Khan SN, Han J, Kalinina O, Luning Prak ET.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11958-63. doi: 10.1073/pnas.1308620110. Epub 2013 Jul 1.

20.

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.

Rickels MR, Liu C, Shlansky-Goldberg RD, Soleimanpour SA, Vivek K, Kamoun M, Min Z, Markmann E, Palangian M, Dalton-Bakes C, Fuller C, Chiou AJ, Barker CF, Luning Prak ET, Naji A.

Diabetes. 2013 Aug;62(8):2890-7. doi: 10.2337/db12-1802. Epub 2013 Apr 29.

21.

TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.

Nickerson KM, Christensen SR, Cullen JL, Meng W, Luning Prak ET, Shlomchik MJ.

J Immunol. 2013 Feb 15;190(4):1447-56. doi: 10.4049/jimmunol.1202115. Epub 2013 Jan 7.

22.

Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity.

Andrews SF, Zhang Q, Lim S, Li L, Lee JH, Zheng NY, Huang M, Taylor WM, Farris AD, Ni D, Meng W, Luning Prak ET, Wilson PC.

J Exp Med. 2013 Jan 14;210(1):125-42. doi: 10.1084/jem.20120525. Epub 2012 Dec 24.

23.

A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort.

Kersun LS, Reilly A, Coffin SE, Boyer J, Luning Prak ET, McDonald K, Hou X, Jawad AF, Sullivan KE.

Influenza Other Respir Viruses. 2013 Nov;7(6):1158-67. doi: 10.1111/irv.12058. Epub 2012 Nov 30.

24.

Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Cines DB, McCrae KR, Zheng XL, Sachais BS, Luning Prak ET, Siegel DL.

Blood. 2012 Nov 15;120(20):4134-42. doi: 10.1182/blood-2012-06-389445. Epub 2012 Sep 10. Review.

25.

Restoring balance to B cells in ADA deficiency.

Luning Prak ET.

J Clin Invest. 2012 Jun;122(6):1960-2. doi: 10.1172/JCI63782. Epub 2012 May 24.

26.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Meng W, Li Y, Xue E, Satoh M, Peck AB, Cohen PL, Eisenberg RA, Luning Prak ET.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6. Epub 2012 Feb 17.

27.

Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.

Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi AK, Luning Prak ET, Meyer-Bahlburg A, Sanda S, Greenbaum C, Rawlings DJ, Buckner JH.

J Immunol. 2012 Jan 1;188(1):487-96. doi: 10.4049/jimmunol.1102176. Epub 2011 Nov 21.

28.

Hypersensitivity to rabbit antithymocyte globulin in an islet transplant recipient: a case report.

Soleimanpour SA, Sekiguchi DR, LaRosa DF, Luning Prak ET, Naji A, Rickels MR.

Transplant Proc. 2011 Nov;43(9):3302-6. doi: 10.1016/j.transproceed.2011.10.004.

29.

Circulating lymphocyte subsets in normal adults are variable and can be clustered into subgroups.

Sekiguchi DR, Smith SB, Sutter JA, Goodman NG, Propert K, Louzoun Y, Rogers W, Luning Prak ET.

Cytometry B Clin Cytom. 2011 Sep;80(5):291-9. doi: 10.1002/cyto.b.20594. Epub 2011 Apr 6.

30.

B cell receptor editing in tolerance and autoimmunity.

Luning Prak ET, Monestier M, Eisenberg RA.

Ann N Y Acad Sci. 2011 Jan;1217:96-121. doi: 10.1111/j.1749-6632.2010.05877.x. Epub 2011 Jan 5. Review.

31.

Age-related trends in pediatric B-cell subsets.

Luning Prak ET, Ross J, Sutter J, Sullivan KE.

Pediatr Dev Pathol. 2011 Jan-Feb;14(1):45-52. doi: 10.2350/10-01-0785-OA.1. Epub 2010 Jul 26.

PMID:
20658930
32.

Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production.

Sonnenberg GF, Mangan PR, Bezman NA, Sekiguchi DR, Luning Prak ET, Erikson J, Maltzman JS, Jordan MS, Koretzky GA.

Blood. 2010 Mar 18;115(11):2186-95. doi: 10.1182/blood-2009-08-237438. Epub 2009 Dec 22.

33.

Antibodies in a heavy chain knock-in mouse exhibit characteristics of early heavy chain rearrangement.

Yunk L, Meng W, Cohen PL, Eisenberg RA, Luning Prak ET.

J Immunol. 2009 Jul 1;183(1):452-61. doi: 10.4049/jimmunol.0804060.

34.

The ITP syndrome: pathogenic and clinical diversity.

Cines DB, Bussel JB, Liebman HA, Luning Prak ET.

Blood. 2009 Jun 25;113(26):6511-21. doi: 10.1182/blood-2009-01-129155. Epub 2009 Apr 24. Review.

35.

2008 ACLPS panel discussion on resident education in clinical pathology.

Luning Prak ET, Young DS, Kamoun M, Nachamkin I, Alexander CB, Spitalnik SL, Peerschke EI, Smith BR.

Am J Clin Pathol. 2009 May;131(5):618-22. doi: 10.1309/AJCPPI03HMYAAEOJ.

PMID:
19369619
36.

RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes.

Panigrahi AK, Goodman NG, Eisenberg RA, Rickels MR, Naji A, Luning Prak ET.

J Exp Med. 2008 Dec 22;205(13):2985-94. doi: 10.1084/jem.20082053. Epub 2008 Dec 15.

37.

A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.

Sutter JA, Kwan-Morley J, Dunham J, Du YZ, Kamoun M, Albert D, Eisenberg RA, Luning Prak ET.

Clin Immunol. 2008 Mar;126(3):282-90. doi: 10.1016/j.clim.2007.11.012. Epub 2008 Jan 15.

PMID:
18226586
38.

DNA damage and L1 retrotransposition.

Farkash EA, Luning Prak ET.

J Biomed Biotechnol. 2006;2006(1):37285.

39.

The potential regulation of L1 mobility by RNA interference.

Horman SR, Svoboda P, Luning Prak ET.

J Biomed Biotechnol. 2006;2006(1):32713.

40.

More active human L1 retrotransposons produce longer insertions.

Farley AH, Luning Prak ET, Kazazian HH Jr.

Nucleic Acids Res. 2004 Jan 23;32(2):502-10. Print 2004.

Supplemental Content

Loading ...
Support Center